Russell Dahl

3.5k total citations
71 papers, 2.8k citations indexed

About

Russell Dahl is a scholar working on Molecular Biology, Organic Chemistry and Cellular and Molecular Neuroscience. According to data from OpenAlex, Russell Dahl has authored 71 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Molecular Biology, 15 papers in Organic Chemistry and 15 papers in Cellular and Molecular Neuroscience. Recurrent topics in Russell Dahl's work include Neuroscience and Neuropharmacology Research (9 papers), Cell death mechanisms and regulation (8 papers) and Melanoma and MAPK Pathways (7 papers). Russell Dahl is often cited by papers focused on Neuroscience and Neuropharmacology Research (9 papers), Cell death mechanisms and regulation (8 papers) and Melanoma and MAPK Pathways (7 papers). Russell Dahl collaborates with scholars based in United States, Russia and Italy. Russell Dahl's co-authors include Nicholas D. P. Cosford, Maurizio Pellecchia, John L. Stebbins, Li Yang, Krisztina M. Zsebo, John C. Reed, Nathaniel S. Finney, Ananda Herath, Roger J. Hajjar and Ying Su and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Russell Dahl

71 papers receiving 2.7k citations

Peers

Countries citing papers authored by Russell Dahl

Since Specialization

Citations

This map shows the geographic impact of Russell Dahl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Russell Dahl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Russell Dahl more than expected).

Fields of papers citing papers by Russell Dahl

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Russell Dahl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Russell Dahl. The network helps show where Russell Dahl may publish in the future.

Co-authorship network of co-authors of Russell Dahl

This figure shows the co-authorship network connecting the top 25 collaborators of Russell Dahl. A scholar is included among the top collaborators of Russell Dahl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Russell Dahl. Russell Dahl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A Positive Allosteric Modulator of the SERCA Pump Rescues Hippocampal Neuronal Circuits Dysfunction and Cognitive Defects in a Mouse Model of Alzheimer's Disease 2025 ·Journal of Neuroscience ·(unknown), (unknown), Ekaterina Pchitskaya, О. Л. Власова, Russell Dahl, Ilya Bezprozvanny	3
2	Positive Allosteric Modulator of SERCA Pump NDC-1173 Exerts Beneficial Effects in Mouse Model of Alzheimer’s Disease 2023 ·International Journal of Molecular Sciences ·Russell Dahl, Amanda Moore, (unknown), (unknown), Hua Zhang, Gary E. Schiltz, Wendy A. Koss, Ilya Bezprozvanny	11
3	Positive Allosteric Modulators of SERCA Pump Restore Dendritic Spines and Rescue Long-Term Potentiation Defects in Alzheimer’s Disease Mouse Model 2023 ·International Journal of Molecular Sciences ·(unknown), (unknown), (unknown), Ekaterina Pchitskaya, Russell Dahl, Ilya Bezprozvanny	7
4	Discovery of 5-((5-chloro-2-methoxyphenyl)sulfonamido)nicotinamide (SBI-425), a potent and orally bioavailable tissue-nonspecific alkaline phosphatase (TNAP) inhibitor 2017 ·Bioorganic & Medicinal Chemistry Letters ·Anthony B. Pinkerton, Eduard Sergienko, (unknown), Russell Dahl, Chen-Ting Ma, Qing Sun, Michael R. Jackson, Nicholas D. P. Cosford, José Luís Millán	31
5	Design and Synthesis of Systemically Active Metabotropic Glutamate Subtype-2 and -3 (mGlu_2/3) Receptor Positive Allosteric Modulators (PAMs): Pharmacological Characterization and Assessment in a Rat Model of Cocaine Dependence 2014 ·Journal of Medicinal Chemistry ·Raveendra-Panickar Dhanya, Douglas J. Sheffler, Russell Dahl, (unknown), (unknown), Li Yang, Hilary Highfield Nickols, Hyekyung P. Cho, Layton H. Smith, Manoranjan S. D’Souza, P. Jeffrey Conn, Andre Der‐Avakian, Athina Markou, Nicholas D. P. Cosford	26
6	Design, Synthesis and Bioevaluation of an EphA2 Receptor‐Based Targeted Delivery System 2014 ·ChemMedChem ·Elisa Barile, Si Wang, Swadesh K. Das, Roberta Noberini, Russell Dahl, John L. Stebbins, Elena B. Pasquale, Paul B. Fisher, Maurizio Pellecchia	33
7	Novel MT1-MMP Small-Molecule Inhibitors Based on Insights into Hemopexin Domain Function in Tumor Growth 2012 ·Cancer Research ·Albert G. Remacle, Vladislav S. Golubkov, Sergey A. Shiryaev, Russell Dahl, John L. Stebbins, Andrei V. Chernov, Anton Cheltsov, Maurizio Pellecchia, Alex Y. Strongin	110
8	A Gatekeeper Residue for NEDD8-Activating Enzyme Inhibition by MLN4924 2012 ·Cell Reports ·Julia I. Toth, Li Yang, Russell Dahl, Matthew D. Petroski	69
9	High-Throughput Fluorescence Polarization Assay for Chemical Library Screening against Anti-Apoptotic Bcl-2 Family Member Bfl-1 2011 ·SLAS DISCOVERY ·Dayong Zhai, Paulo H. Godoi, Eduard Sergienko, Russell Dahl, (unknown), Brock Brown, (unknown), (unknown), Ying Su, Thomas D.Y. Chung, Chaofang Jin, Paul Diaz, John C. Reed	17
10	Design, synthesis, and structure–activity relationship studies of thiophene-3-carboxamide derivatives as dual inhibitors of the c-Jun N-terminal kinase 2011 ·Bioorganic & Medicinal Chemistry ·Surya K. De, Elisa Barile, (unknown), John L. Stebbins, Jason Cellitti, Thomas Machleidt, Coby B. Carlson, Li Yang, Russell Dahl, Maurizio Pellecchia	13
11	Design and Synthesis of an Orally Active Metabotropic Glutamate Receptor Subtype-2 (mGluR2) Positive Allosteric Modulator (PAM) That Decreases Cocaine Self-Administration in Rats 2010 ·Journal of Medicinal Chemistry ·Raveendra-Panickar Dhanya, Shyama Sidique, Douglas J. Sheffler, Hilary Highfield Nickols, Ananda Herath, Li Yang, Russell Dahl, Robert Ardecky, Svetlana Semenova, Athina Markou, P. Jeffrey Conn, Nicholas D. P. Cosford	36
12	Apogossypol derivatives as antagonists of antiapoptotic Bcl-2 family proteins 2009 ·Molecular Cancer Therapeutics ·Jun Wei, Shinichi Kitada, Michele F. Rega, Aras Emdadi, Hongbin Yuan, Jason Cellitti, John L. Stebbins, Dayong Zhai, Jiazhi Sun, Li Yang, Russell Dahl, Ziming Zhang, Bainan Wu, Si Wang, (unknown), Nicholas J. Lawrence, Saı̈d M. Sebti, John C. Reed, Maurizio Pellecchia	51
13	In vivo antitumor effect of a novel inhibitor of protein geranylgeranyltransferase-I 2009 ·Molecular Cancer Therapeutics ·Jie Lü, Lai N. Chan, Hannah D.G. Fiji, Russell Dahl, Ohyun Kwon, Fuyuhiko Tamanoi	64
14	Discovery and Binding Studies on a Series of Novel Pin1 Ligands 2009 ·Chemical Biology & Drug Design ·Bainan Wu, Michele F. Rega, Jun Wei, Hongbin Yuan, Russell Dahl, Ziming Zhang, Maurizio Pellecchia	9
15	Synthesis and optimization of thiadiazole derivatives as a novel class of substrate competitive c-Jun N-terminal kinase inhibitors 2009 ·Bioorganic & Medicinal Chemistry ·Surya K. De, (unknown), John L. Stebbins, Li‐Hsing Chen, Jason Cellitti, Thomas Machleidt, Elisa Barile, Megan Riel‐Mehan, Russell Dahl, Li Yang, Aras Emdadi, (unknown), Maurizio Pellecchia	16
16	‘Reverse’ α-ketoamide-based p38 MAP kinase inhibitors 2008 ·Bioorganic & Medicinal Chemistry Letters ·Antonio Montalbán, (unknown), (unknown), (unknown), Russell Dahl, (unknown), (unknown), (unknown), Andrew R. Gibbs, (unknown), Linda Kessler, Jan O. Lundström, Stephen E. Miller, Hiroshi Nakanishi, (unknown), Eddine Saiah, (unknown), Zhijun Wang, Christopher J. Larson	14
17	Small Molecules Can Selectively Inhibit Ephrin Binding to the EphA4 and EphA2 Receptors 2008 ·Journal of Biological Chemistry ·Roberta Noberini, Mitchell Koolpe, Satyamaheshwar Peddibhotla, Russell Dahl, Ying Su, Nicholas D. P. Cosford, Gregory P. Roth, Elena B. Pasquale	113
18	Preclinical Studies of Celastrol and Acetyl Isogambogic Acid in Melanoma 2007 ·Clinical Cancer Research ·Sabiha Abbas, Anindita Bhoumik, Russell Dahl, Stefan Vasile, Stan Krajewski, Nicholas D. P. Cosford, Ze’ev A. Ronai	83
19	HTS Identifies Novel and Specific Uncompetitive Inhibitors of the Two-Component NS2B-NS3 Proteinase of West Nile Virus 2007 ·Assay and Drug Development Technologies ·Paul A. Johnston, Jennifer Phillips, Tong Ying Shun, Sunita Shinde, John S. Lazo, Donna M. Huryn, Michael C. Myers, Boris I. Ratnikov, Jeffrey W. Smith, Ying Su, Russell Dahl, Nicholas D. P. Cosford, Sergey A. Shiryaev, Alex Y. Strongin	85
20	Anti-HIV-1 entry optimization of novel imidazopiperidine-tropane CCR5 antagonists 2007 ·Bioorganic & Medicinal Chemistry Letters ·Justin T. Ernst, Russell Dahl, (unknown), (unknown), Ján Urban, Stephen G. Miller, Jan O. Lundström	15

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact